Kalipada Pahan

Kalipada Pahan, Professor of Neurological Sciences, Biochemistry and Pharmacology, and the Floyd A. Davis, M.D., Endowed Chair in Neurology in Rush University Medical Center, is an eminent Indian American neuroscientist involved in translational research on multiple sclerosis, Parkinson's disease, Alzheimer's disease, dementia, and Batten disease. He is known for his research on statins, cholesterol-lowering drugs. He first explored the application of statins in suppressing the inflammatory events in microglia, astroglia and macrophages. This finding has revolutionized the research on statin drugs. Later his lab has shown that statins may be beneficial in protecting neurons and improving locomotor activities in Parkinson's disease by suppressing the activation of p21/Ras. Recently his lab has delineated a unique crosstalk between fat and memory in which the lipid-lowering transcription factor PPARalpha controls the formation of hippocampal memory via transcriptional regulation of CREB (Roy et al., 2013, Cell Reports 4: 724-737). He has published more than 150 papers in many peer-reviewed journals including Journal of Biological Chemistry, Journal of Immunology, Journal of Neuroscience, Cell Death and Differentiation, Proceedings of the National Academy of Sciences of the USA, Journal of Clinical Investigation, Cell Reports, Cell Metabolism, and Nature Chemical Biology. He is the recipient of "D. H. Reinhardt Scholar" award from the University of Nebraska Medical Center (UNMC) College of Dentistry, the "Silver U" award from the UNMC Chancellor's council and the outstanding teaching award from the UNMC College of Dentistry. He also received the Zenith Fellows Award from the Alzheimer's Association.